Castle Biosciences Inc at Canaccord Genuity Growth Conference Transcript
Welcome to the Canaccord Genuity global growth conference. I'm Kyle Mikson, over at life science, tools, and diagnostics for Canaccord. Pleased to have Castle Biosciences here with us today. Castle is a company that provides many diagnostic tests across dermatology, cancer, mental health, and GI cancer as well. So we have Derek Maetzold, the CEO of the company, and he's going to run through some slides to start us off. So go ahead, Derek, thanks for joining.
Thank you, Kyle and Canaccord, for the opportunity to be here in Boston yet again. Let's get started here. So let's see, disclaimer slide. So Castle Biosciences is a molecular diagnostics company predominantly focused on providing high-value diagnostic tests that help inform better patient management for a variety of conditions. Our largest franchise is in dermatology, where we have three proprietary gene expression profile tests: DecisionDX-Melanoma, DecisionDx-SCC, and MyPath Melanoma.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |